| Symbol | LUCD |
|---|---|
| Name | LUCID DIAGNOSTICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 60 EAST 42ND STREET,SUITE 4600, NEW YORK, New York, 10165, United States |
| Telephone | +1 212 949-4319 |
| Fax | — |
| — | |
| Website | https://www.luciddx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001799011 |
| Description | Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Additional info from NASDAQ: |
(30% Negative) LUCID DIAGNOSTICS INC. (LUCD) Reports Q3 2026 Financial Results
Read moreLucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
Read moreLucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
Read moreLucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
Read moreLucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
Read moreDirector Matheis Dennis 🟢 acquired 245.0K shares of Lucid Diagnostics Inc. (LUCD) at $1.00 Transaction Date: May 20, 2026 | Filing ID: 000217
Read more(30% Negative) LUCID DIAGNOSTICS INC. (LUCD) Reports Q2 2026 Financial Results
Read moreLucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT06532734 | Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype | — | Barrett Esophagus | Recruiting | 2024-11-12 | 2026-11-01 | ClinicalTrials.gov |
| NCT05778851 | Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as … | Na | Barrett Esophagus | Completed | 2023-04-12 | 2024-08-19 | ClinicalTrials.gov |
| NCT05965999 | Lucid Registry Study | — | Barrett Esophagus | Unknown | 2023-04-11 | 2024-06-01 | ClinicalTrials.gov |
| NCT06030180 | CLUE: CLinical Utility Study of EsoGuard | Na | Barrett Esophagus | Completed | 2023-02-23 | 2024-12-13 | ClinicalTrials.gov |
| NCT04311970 | Pilot Study of Esocheck in Eosinophilic Esophagitis | Na | Eosinophilic Esophagitis | Completed | 2020-08-05 | 2021-08-23 | ClinicalTrials.gov |
| NCT04295811 | Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck … | Na | Barrett Esophagus | Unknown | 2020-06-18 | 2023-12-01 | ClinicalTrials.gov |
| NCT04293458 | Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Dia… | Na | Barrett Esophagus | Completed | 2020-02-28 | 2022-08-22 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| EsoCheck | Other | Approved | Eosinophilic Esophagitis | COMPLETED | NCT04311970 |
| Esophagogastroduodenoscopy | Other | Approved | Barrett Esophagus | UNKNOWN | NCT04295811 |
| EsoGuard (lab assay) | Other | Approved | Barrett Esophagus | UNKNOWN | NCT04295811 |
| EsoGuard | Other | Approved | Barrett Esophagus | COMPLETED | NCT04293458 |
| EsoCheck | Other | Preclinical | Barrett Esophagus | UNKNOWN | NCT05965999 |
| EsoGuard | Other | Approved | Barrett Esophagus | COMPLETED | NCT06030180 |
| EsoGuard result | Other | Approved | Barrett Esophagus | COMPLETED | NCT05778851 |
| EsoGuard | Other | Preclinical | Barrett Esophagus | RECRUITING | NCT06532734 |
| EsoGuard result | DEVICE | Approved | Barrett Esophagus | COMPLETED | NCT05778851 |
| EsoCheck | DEVICE | Preclinical | Barrett Esophagus | UNKNOWN | NCT05965999 |
| EsoGuard (lab assay) | DEVICE | Approved | Barrett Esophagus | UNKNOWN | NCT04295811 |
| EsoGuard | DEVICE | Preclinical | Barrett Esophagus | RECRUITING | NCT06532734 |